HUMAN HEALTH
It is well known that leisure, when balanced with other aspects of life, contributes to a person’s overall well-being. This is where casinos with a $10 deposit https://casinospacebe.com/10-euro-deposit-casino/ can help. These platforms are designed for people who love online gaming but also value their financial responsibility. For a modest deposit of $10, participants can immerse themselves in the world of exciting casino games without worrying about significant financial commitments. Whether you are an online slots enthusiast or prefer a classic round of poker, these casinos have something for everyone.
At Innocan Pharma, we support a balanced lifestyle that includes health and leisure. We believe that self-care involves more than just medicine and includes activities that you enjoy. We are here to remind you that your health is important, as is the time you devote to yourself.
Addressing a Real Clinical Need
Chronic pain affects nearly 1 in 5 adults in the U.S. and Europe, significantly impacting their quality of life. Traditional treatments have contributed to adverse consequences, including the opioid epidemic, with over 75% of drug overdose deaths in the U.S attributed to opioids. This crisis highlights the urgent need for safer, more effective pain management solutions.
Innovative LPT-CBD
Our unique LPT-CBD injectable drug provides sustained-release of synthetic CBD with the following key advantages:
- High Bioavailability: Nearly 100% CBD bioavailability ensures maximum therapeutic effect.
- Prolonged Efficacy: A single injection offers continuous relief that can be equivalent to administering oral CBD twice a day for up to 4 weeks
- Safety: LPT-CBD is expected to avoid the risks associated with opioid treatments and traditional chronic pain management.
Market Impact
The global pain management market is projected to reach $109 billion by 2032, with chronic pain accounting for 58% of this market. Our LPT-CBD injection aims to capture a significant share by addressing the unmet needs of millions suffering from chronic pain.
Pre-Clinical Successes
LPT-CBD has shown promising results in preclinical and observational studies conducted on various animal models:
- Goats: Presented long CBD exposure for 4 weeks and provided significant pain relief resulting from neurological defects and scoliosis while enhancing overall well-being
- Donkey: Provided immediate pain relief and improved mobility for an amputee suffering from Laminitis
- Mini Pigs: Demonstrated prolonged CBD release, favorable safety profile and good drug tolerance with no adverse events
- Rabbits: Supported prolonged CBD exposure from a single injection
Regulatory Progress
We have commenced the FDA regulatory review process for this non-opioid chronic pain therapy, beginning with a successful pre-IND meeting that structured our development plan towards IND submission.
Commitment to Advancing Human Health
We are dedicated to improving human health through scientific innovation. LPT-CBD addresses real clinical needs, enhancing the lives of those suffering from chronic pain.
Discover how Innocan is setting new standards in pain management with our groundbreaking LPT-CBD injection.
SOCIAL MEDIA
